0001562180-16-002821.txt : 20160719 0001562180-16-002821.hdr.sgml : 20160719 20160719183408 ACCESSION NUMBER: 0001562180-16-002821 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160718 FILED AS OF DATE: 20160719 DATE AS OF CHANGE: 20160719 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Intersect ENT, Inc. CENTRAL INDEX KEY: 0001271214 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 200280837 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1555 ADAMS DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650-641-2100 MAIL ADDRESS: STREET 1: 1555 ADAMS DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 FORMER COMPANY: FORMER CONFORMED NAME: SINEXUS INC DATE OF NAME CHANGE: 20031124 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stambaugh James CENTRAL INDEX KEY: 0001614498 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36545 FILM NUMBER: 161774289 MAIL ADDRESS: STREET 1: 1555 ADAMS DRIVE STREET 2: C/O INTERSECT ENT, INC. CITY: MENLO PARK STATE: CA ZIP: 94025 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2016-07-18 false 0001271214 Intersect ENT, Inc. XENT 0001614498 Stambaugh James C/O INTERSECT ENT, INC., 1555 ADAMS DR. MENLO PARK CA 94025 false true false false VP Clinical Affairs Common Stock 2016-07-18 4 M false 5000.00 0.48 A 29000.00 D Common Stock 2016-07-18 4 S false 5000.00 15.3286 D 24000.00 D Stock Option (right to buy) 0.48 2016-07-18 4 M false 3062.00 0.00 D 2016-11-16 Common Stock 3062.00 0.00 D Stock Option (right to buy) 0.48 2016-07-18 4 M false 1938.00 0.00 D 2017-08-21 Common Stock 1938.00 14693.00 D The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2016. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.27 to $15.39, inclusive. The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote on this Form 4. The shares subject to the option are immediately exercisable. 1/48th of the shares subject to the option vest monthly over 48 months beginning October 23, 2007. The shares subject to the option are immediately exercisable. 1/48th of the shares subject to the option vest monthly over 48 months beginning August 22, 2007. /s/ Jeryl L. Hilleman, Attorney-in-Fact for James W. Stambaugh 2016-07-19